NIH-funded research R01 grant

Creating better models for studying ovarian cancer cells

Official title: Culture of tumor versus normal cells

Funded at Weill Medical Coll of Cornell Univ · NIH-10992189 · Data updated 2026-11-12

This study is working on better ways to grow ovarian cancer cells in the lab so that researchers can create more accurate models to understand the disease and develop more effective treatments, which could ultimately help patients like you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$364,140
NIH project number5R01CA285335-02
Project IDNIH-10992189 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with ovarian cancer who are undergoing treatment.

Less likely to help

Patients with non-cancerous conditions or those not diagnosed with ovarian cancer may not receive any benefit from this research.

What this research studies

This research focuses on developing improved methods for culturing tumor cells from ovarian cancer patients, which can help create more accurate models for studying cancer. The team aims to address the challenge of normal cells outgrowing cancer cells in laboratory settings by designing a specialized medium that suppresses normal cell growth. By establishing patient-derived cell cultures and xenograft models, the research seeks to better reflect the diversity of human cancer and improve the development of targeted therapies. Patients may benefit from the insights gained through these innovative models, which could lead to more effective treatments.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatments for ovarian cancer patients.

How similar studies have gone: Other research has shown success in developing patient-derived models for cancer, but this approach aims to innovate further in the field.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Ince, Tan a. — Weill Medical Coll of Cornell Univ
  • Study coordinator: Ince, Tan a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.